Rx-to-OTC Switch

Browse Rx-to-OTC Switch Content

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details.

Oct 13, 2021

RSQ showcased the increased conversation around Rx-to-OTC switch among regulators, industry experts, and other stakeholders.

Sep 20, 2021

Janet Woodcock, Cara Welch, other consumer healthcare leaders to discuss emerging trends in OTCs, dietary supplements, and consumer medical devices

Aug 12, 2021

Just prior to the 4th of July holiday, the House Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, Appropriations Subcommittee released its FY 2022 Report.

Jul 7, 2021

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details. 

Jun 23, 2021

Now from coast-to-coast, it is once again legal to purchase cold and allergy medicines containing the decongestant pseudoephedrine (PSE) over-the-counter (OTC). In a major victory for consumers, Oregon has repealed a 15-year-old law that banned OTC sales of certain medicines for colds and allergies containing PSE.

Jun 17, 2021

At a June 6 hearing on the FY 2022 FDA Budget, Senate Agriculture-FDA Appropriations Subcommittee Ranking Member, Senator John Hoeven (R-N.D.) asked Acting FDA Commissioner Janet Woodcock about delays with the Non-Prescription Safe Use Regulatory Expansion (NSURE) final rule.

Jun 16, 2021

CHPA congratulates Patrizia Cavazzoni on her recent appointment as director of FDA’s Center for Drug Evaluation and Research (CDER).

Apr 13, 2021

Cindy Sanders discusses a recent study examining the growing interest in OTC access to oral contraceptives.

Jan 8, 2021

Filter Results